Prosecution Insights
Last updated: May 29, 2026

Examiner: LEVERETT, MARY CHANG

Tech Center 1600 • Art Units: 1672 1682 1687

This examiner grants 60% of resolved cases

Performance Statistics

60.5%
Allow Rate
+0.5% vs TC avg
110
Total Applications
+22.6%
Interview Lift
1506
Avg Prosecution Days
Based on 86 resolved cases, 2023–2026

Rejection Statute Breakdown

27.3%
§101 Eligibility
6.3%
§102 Novelty
55.4%
§103 Obviousness
1.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17610788 ASSESSMENT OF MULTIPLE SIGNALING PATHWAY ACTIVITY SCORE IN AIRWAY EPITHELIAL CELLS TO PREDICT AIRWAY EPITHELIAL ABNORMALITY AND AIRWAY CANCER RISK Non-Final OA KONINKLIJKE PHILIPS N.V.
17898240 SYSTEMS AND METHODS FOR IDENTIFYING ADAPTIVE IMMUNE CELL CLONOTYPES Non-Final OA 10x Genomics, Inc.
17876065 SYSTEM AND METHOD FOR CONTROLLING CELL FUNCTIONING AND MOTILITY WITH THE AID OF A DIGITAL COMPUTER Non-Final OA XEROX CORPORATION
17904675 METHOD AND SYSTEM FOR ADVERSARY RESILIENT SCREENING OF SYNTHETIC GENE ORDERS Non-Final OA B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY
16632899 SYSTEMS AND METHODS FOR TARGETED GENOME EDITING Non-Final OA PIONEER HI-BRED INTERNATIONAL, INC.
17244711 SYSTEMS AND METHODS FOR REINFORCEMENT LEARNING MOLECULAR MODELING Final Rejection UCHICAGO ARGONNE, LLC
17995525 METHOD FOR IDENTIFYING SIGNATURES FOR PREDICTING TREATMENT RESPONSE Non-Final OA UMC Utrecht Holding B.V.
17759779 METABOLOMICS RELATIVE QUANTITATIVE ANALYSIS METHOD BASED ON UPLC/HMRS Non-Final OA Suzhou Bionovogene Biomedical Tech Co., Ltd
17780001 METHOD AND SYSTEM FOR TRAINING ARTIFICIAL INTELLIGENCE MODEL FOR ESTIMATION OF GLYCOLYTIC HEMOGLOBIN LEVELS Non-Final OA MONORAMA CO., LTD.
17534000 METHODS AND KITS FOR DETECTING PATHOGENS Non-Final OA Clear Labs, Inc.
17532821 ASSESSMENT OF EXPOSURE TO AIRBORNE PATHOGENS Non-Final OA Signature Science, LLC
17042771 METHOD AND SYSTEM FOR COMPUTATIONAL MODELLING AND SIMULATION APPLIED TO DRUG CHARACTERIZATION AND/OR OPTIMIZATION Final Rejection INSILICOTRIALS TECHNOLOGIES S.r.l.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month